Current smoking status is associated to a non-ACR 50 response in early rheumatoid arthritis. A cohort study

Clinical Rheumatology

Volumn 30, Issue 12, 2011, Pages 1589-1593

  Rojas Serrano, Jorge ^a   Pérez, Leticia Lino ^b   García, Conrado García ^b   Moctezuma, Francisco ^b   Álvarez Hernández, Everardo ^b   Vázquez Mellado, Janitzia ^b,c   Montiel, José Luis ^d   Burgos Vargas, Rubén ^b,c  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

Author keywords

Early rheumatoid arthritis; Methotrexate; Prognostic factors; Rheumatoid arthritis; Sulfasalazine

Indexed keywords

METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ARTHROPATHY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; EARLY RHEUMATOID ARTHRITIS; FEMALE; FOLLOW UP; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JOINT SWELLING; JOINT TENDERNESS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SMOKING; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; SMOKING; SULFASALAZINE; TREATMENT OUTCOME;

EID: 82655182044     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1775-5     Document Type: Article

References (27)

1. Gordon DA, Hastings DE (2003) Clinical features of rheumatoid arthritis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblat ME, Weisman MH (eds) Rheumatology, 3rd edn. Mosby, Edinburgh, pp 765-780
2. D Van der Heijde PL van Riel HH Nuver-Zwart FW Gribnau LBA van de Putte 1989 Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis Lancet 1 1036 1038 2565997 10.1016/S0140-6736(89) 92442-2 (Pubitemid 19123055)
3. C Egsmose B Lund G Borg H Pettersson E Berg U Brodin L Trang 1995 Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5-year followup of a prospective double blind placebo controlled study J Rheumatol 22 2208 2213 8835550 1:STN:280:DyaK28vjt1Crtg%3D%3D
4. M Abu-Shakra R Toker D Flusser G Flusser M Friger S Sukenik D Buskila 1998 Clinical and radiographic outcomes of rheumatoid arthritis patients not treated with disease-modifying drugs Arthritis Rheum 41 1190 1195 9663474 10.1002/1529-0131(199807)41:7<1190::AID-ART7>3.0.CO;2-B 1:STN:280:DyaK1czis1KjtQ%3D%3D (Pubitemid 28313419)
5. HK Choi MA Hernán JD Seeger JM Robins F Wolfe 2002 Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study Lancet 359 1173 1177 11955534 10.1016/S0140-6736(02)08213-2 1:CAS:528: DC%2BD38XivVShsrw%3D (Pubitemid 34304256)
6. D Krause B Schleusser G Herborn R Rau 2000 Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis Arthritis Rheum 43 14 21 10643695 10.1002/1529-0131(200001) 43:1<14::AID-ANR3>3.0.CO;2-7 1:CAS:528:DC%2BD3cXns1yhtg%3D%3D (Pubitemid 30368208)
7. T Möttönen P Hannonen M Leirisalo-Repo, et al. 1999 Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomized trial Lancet 353 1568 1573 10334255 10.1016/S0140-6736(98)08513-4 (Pubitemid 29219206)
8. C Grigor H Appel A Stirling, et al. 2004 Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomized controlled trial Lancet 364 263 269 15262104 10.1016/S0140-6736(04) 16676-2 (Pubitemid 38942816)
9. J Rojas-Serrano R Burgos-Vargas L Lino-Pérez 2010 El tabaquismo se asocia a una falla para alcanzar una respuesta ACR 50. Estudio de cohorte de pacientes con artritis reumatoide de inicio reciente Reumatol Clin 6 s39 s40
10. L Gossec M Dougados P Goupille, et al. 2004 Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study Ann Rheum Dis 63 675 680 15140774 10.1136/ard.2003.010611 1:STN:280: DC%2BD2c3ktFKgsw%3D%3D (Pubitemid 38658397)
11. SL Hider C Buckley AJ Silman DPM Symmons IN Bruce 2005 Factors influencing response to disease modifying antirheumatic drugs in patients with rheumatoid arthritis J Rheumatol 32 11 16 15700388 (Pubitemid 40092583)
12. JJ Anderson G Wells AC Verhoven DT Felson 2000 Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration Arthritis Rheum 43 22 29 10643696 10.1002/1529-0131(200001)43:1<22:: AID-ANR4>3.0.CO;2-9 1:STN:280:DC%2BD3c7gs1Cqsg%3D%3D (Pubitemid 30368209)
13. P Ranganathan HL McLeod 2006 Methotrexate pharmacogenetics. The first step toward individualized therapy in rheumatoid arthritis Arthritis Rheum 54 1366 1377 16645965 10.1002/art.21762 1:CAS:528:DC%2BD28XlsFSqurw%3D
14. YC Lee J Cui KH Costenbader, et al. 2009 Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate Rheumatology 48 613 617 19193698 10.1093/rheumatology/ken513 1:CAS:528:DC%2BD1MXmtFCjtb4%3D
15. T Derviux 2009 Methotrexate pharmacogenomics in rheumatoid arthritis: introducing false-positive report probability (editorial) Rheumatology 48 1619 1620 10.1093/rheumatology/kep322
16. FC Arnett SM Edworthy DA Bloch, et al. 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 3358796 10.1002/art.1780310302 1:STN:280: DyaL1c7pt1Ohsg%3D%3D (Pubitemid 18091653)
17. MH Cardiel M Abello-Banfi R Ruiz-Mercado D Alarcón-Segovia 1993 How to measure health status in rheumatoid arthritis in non-English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI) Clin Exp Rheumatol 11 117 121 8508553 1:STN:280:DyaK3s3osVOmtg%3D%3D (Pubitemid 23155978)
18. JS Smolen FC Breedveld MH Schiff, et al. 2003 A simplified disease activity index for rheumatoid arthritis for use in clinical practice Rheumatology 42 244 257 12595618 10.1093/rheumatology/keg072 1:CAS:528:DC%2BD3sXit1yntLs%3D (Pubitemid 36305610)
19. DT Felson JJ Anderson M Boers, et al. 1995 American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis Arthritis Rheum 38 727 735 7779114 10.1002/art.1780380602 1:STN:280: DyaK2M3pvVSmtA%3D%3D
20. MP Vessey L Villard-MAckintosh D Yeates 1987 Oral contraceptives, cigarette smoking and other factors in relation to arthritis Contraception 35 457 464 3621942 10.1016/0010-7824(87)90082-5 1:STN:280:DyaL2szgtlSmtg%3D%3D (Pubitemid 17139027)
21. AJ Silman J Newman AJ Mac Gregor 1996 Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins Arthritis Rheum 39 732 735 8639169 10.1002/art. 1780390504 1:STN:280:DyaK283ht1CgsQ%3D%3D (Pubitemid 26140417)
22. DP Symmons CR Bankhead BJ Harrison, et al. 1997 Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England Arthritis Rheum 40 1955 1961 9365083 10.1002/art.1780401106 1:STN:280:DyaK1c%2FjtVeltw%3D%3D (Pubitemid 27494654)
23. EW Karlson IM Lee NR Cook JE Manson JE Buring CH Hennekens 1999 A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals Arthritis Rheum 42 910 917 10323446 10.1002/1529-0131(199905)42:5<910::AID-ANR9>3.0.CO;2-D 1:STN:280:DyaK1M3lsFShtw%3D%3D (Pubitemid 29215001)
24. L Padyukov C Silva P Stolt L Alfredsson L Klareskog 2004 A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis Arthritis Rheum 50 3085 3092 15476204 10.1002/art.20553 1:CAS:528:DC%2BD2cXpvFaisbw%3D (Pubitemid 39371983)
25. L Klareskog P Stolt K Lundberg, et al. 2006 A new model for an etiology of rheumatoid arthritis. Smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination Arthritis Rheum 54 38 46 16385494 10.1002/art.21575 1:CAS:528:DC%2BD28XhsVens78%3D (Pubitemid 43122184)
26. JAM Wessels SM van der Kooij S le Cessie, et al. 2007 A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent onset rheumatoid arthritis Arthritis Rheum 56 1765 1775 17530705 10.1002/art.22640 1:CAS:528:DC%2BD2sXnsVOht7o%3D (Pubitemid 47110376)
27. S Saevarsdottir S Wedrén M Seddighzadeh, et al. 2009 Smoking is associated with non response to methotrexate and to anti-TNF treatment in patients with rheumatoid arthritis. Results from Swedish EIRA study (abstract) Arthritis Rheum 60 S237 S238